RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2006;17:30-33
doi:10.1258/095646206775220469
© 2006 Royal Society of Medicine Press

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jabeen, K.
Right arrow Articles by Hasan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original research articles

Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan

Kauser Jabeen, Erum Khan and Rumina Hasan

Pathology/Microbiology Department, Aga Khan University, Karachi, Pakistan; Pathology/Microbiology Department, Aga Khan University, Karachi, Pakistan; Pathology/Microbiology Department, Aga Khan University, Karachi, Pakistan

Quinolone-resistant Neisseria gonorrhoeae (QRNG) have not been reported from Pakistan to date. This is the first report of the presence of QRNG in Pakistan. The study was performed at a tertiary care hospital laboratory in Karachi, Pakistan. Antimicrobial susceptibility data on all N. gonorrhoeae isolated between 1992 and 2002 were retrieved and analysed. Minimum inhibitory concentrations (MICs) of QRNG isolated in year 2002 were performed, and clinical information was collected. QRNG was first noted in 1999 and its proportion increased to 42% in 2002. MICs of the 12 isolates tested in 2002 showed a high level of resistance to ofloxacin with MIC of more than 4 µg/mL. Clinical information from patients with QRNG showed treatment failure. Emergence of QRNG in developing countries is alarming as there is no proper surveillance of increase in resistance. We strongly urge the need of detection and documentation of the resistant gonococcal isolates, as in vitro resistance is associated with clinical failure.

Key Words: N. GONORRHOEAE • QUINOLONE • PAKISTAN • GONORRHOEA • TREATMENT FAILURE WITH QUINOLONE


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Int J STD AIDSHome page
M. J Siedner, M. Pandori, S. R Leon, P. M Barry, B. J Espinosa, E. R Hall, T. J Coates, J. D Klausner, and the NIMH Collaborative HIV/STD Prevention Trial Gr
Detection of quinolone-resistant Neisseria gonorrhoeae in urogenital specimens with the use of real-time polymerase chain reaction
Int J STD AIDS, January 1, 2008; 19(1): 69 - 71.
[Full Text] [PDF]



How Not to be a Doctor